Computational intelligence and servo-mechanical agility are advancing fast, but physical robots still meet the world through their outer surface. BSF Enterprise PLC (LSE: BSFA), via subsidiary 3D Bio-Tissues, is exploring whether bio-engineered skin equivalents can outperform the synthetic materials robots rely on today.

Legacy approach

Synthetic elastomers

Silicones, polyurethanes and synthetic rubbers currently form the outer interface of most humanoid and autonomous robots.

Under continuous operational demand, these materials show real-world limits in flexural wear, joint strain and long-term degradation.

BSF approach

Cell-grown biological surfaces

3DBT's proprietary, continuous biomanufacturing process produces cell-derived tissue that replicates the native structure of skin, applied directly onto complex electromechanical chassis.

Nature-evolved compliance and flexure target the joint articulation points where synthetics face the most stress, while also making human-robot interaction feel more natural.

Commercial integration framework

BSF operates as a specialised technology and materials platform partner to global robotics OEMs and Tier-1 developers. Collaborations run through technical evaluation programmes and Joint Development Agreements — a capital-light model that lets industrial partners evaluate custom biological surfaces while BSF retains full ownership of its patents, cell-derived workflows and platform IP.

Technical evaluation programmes

Joint development agreements

100% IP retained by BSF

Dr Che Connon, CEO, BSF Enterprise PLC

As robotics move into demanding real-world use, outer surface engineering is a foundational material challenge — and BSF's tissue-engineering capability offers manufacturers a natural, bio-engineered alternative to legacy synthetic coverings.

Engineering cell-grown tissues: robotic interfaces

Synthetic elastomers

Cell-grown biological surfaces

Commercial integration framework

Dr Che Connon, CEO, BSF Enterprise PLC